ArticleInternational journal of clinical oncology2022
HER2-low breast cancer could be associated with an increased risk of brain metastasis.
Deniz Can Guven et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled itcites it